Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population

Journal of Clinical Pathology

Volumn 57, Issue 1, 2004, Pages 68-72

  Cuschieri, K S ^a   Cubie, H A ^a   Whitley, M W ^b   Seagar, A L ^a   Arends, M J ^c   Moore, C ^a   Gilkisson, G ^a   McGoogan, E ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b St Triduanas Medical Practice   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASSAY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOLOGY; DEVICE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSKARYOSIS; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; LIQUID; MAJOR CLINICAL STUDY; MATERIALS; POLYMERASE CHAIN REACTION; POPULATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAMPLE; SCREENING; SUPERINFECTION; UTERINE CERVIX TUMOR; VIRUS INFECTION; WART VIRUS;

ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SCOTLAND; UTERINE CERVICAL NEOPLASMS;

EID: 0345863816     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.57.1.68     Document Type: Article

References (24)

1. Zielinski GD, Snijders PJ, Rozendaal L, et al. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer 2001;85:298-404.
2. Kjaer SK, van den Brule, AC, Paull G, et al. Type specific persistence of high-risk human papillomavirus (HPV) as an indicator of high grade squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002;325:572-6.
3. Cuschieri KS, Seagar AL, Moore C, et al. Development of an automated extraction procedure for detection of human papillomavirus DNA in liquid based cytology samples. J Virol Methods 2003;107:107-13.
4. Cubie HA, Seagar AL, McGoogan EM, et al. Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18. Mol Pathol 2001;54:24-9.
5. Gravitt PE, Peyton CL, Apple RJ, et al. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridisation, reverse line blot detection. J Clin Microbiol 1998;36:3020-7.
6. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-61.
7. Whitley MW. Liquid based cytology: a success. BMJ 2003;327:161-2; author reply 162.
8. Molano M, Posso H, Weiderpass E, et al. Prevalence and determinants of HPV infection among Columbian women with normal cytology. Br J Cancer 2002;87:324-33.
9. Rolón PA, Smith JS, Muñoz N, et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000;85:486-91.
10. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human popillomavirus detection in a US population. J Infect Dis 2001;183:1554-64.
11. Burk RD, Kelly P, Feldman J, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1993;20:333-41.
12. Melkert PWJ, Hopman E, van den Brule AJC, et al. Prevalence of HPV in cytomorphologically normal cervical smears as determined by the polymerase chain reaction is age-dependent. Int J Cancer 1993;53:919-23.
13. Cuzick J, Berverley E, Ho L, et al. HPV testing in primary screening of older women. Br J Cancer 1999;81:554-8.
14. Muñoz N, Kato I, Bosch FX, et al. Risk factor for HPV detection in middle-age women. Sex Transm Dis 1996;23:743-9.
15. Chan PKS, Chang AR, Cheung JLK, et al. Determinants of cervical human papillomavirus infection: differences between high and low-oncogenic risk types. J Infect Dis 2002;185:28-35.
16. Muñoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
17. Bachtiary B, Obermair A, Dreier, et al. Impact of multiple infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer 2002;102:237-43.
18. ALTS Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomised trial. J Natl Cancer Inst 2000;92:397-402.
19. Levi JE, Kleter B, Quint WG, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002;9:3341-5.
20. Becker TM, Wheeler CM, McGrough NS, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among Southwestern Hispanic and non-Hispanic white women. JAMA 1994;271:1181-8.
21. Fife KH, Craner HM, Schroeder JM, et al. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 2001;64:550-9.
22. Thomas KK, Hughes JP, Kuypers JM, et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000;182:1097-102.
23. Rousseau MC, Pereira JS, Prado JCM, et al. Cervical coinfection with human papillomavirus types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001;184:1508-17.
24. Chaouki N, Bosch FX, Muñoz N, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998;75:546-55.